Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Nowak

Showing results (51-60 of 187) with videos related to

Pageof 19
Sort By:
Pharmacological Reports : PR|August 17, 2013
Zinc deficiency alters responsiveness to antidepressant drugs in miceKatarzyna Młyniec, Bogusława Budziszewska, Witold Reczyński, et al.
European Journal of Pharmacology|May 18, 2004
Zinc treatment induces cortical brain-derived neurotrophic factor gene expressionGabriel Nowak, Beata Legutko, Bernadeta Szewczyk, et al.
Molecules (Basel, Switzerland)|January 11, 2022
Antidepressant-like Effects of Combined Fluoxetine and Zinc Treatment in Mice Exposed to Chronic Restraint Stress Are Related to Modulation of Histone DeacetylasePaulina Misztak, Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, et al.
Neurotoxicity Research|June 4, 2017
Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in RodentsPiotr Popik, Małgorzata Hołuj, Tomasz Kos, et al.
Polish Journal of Pharmacology|July 26, 2002
Effect of imipramine on brain D-1 and 5-HT-2A receptors in a chronic unpredictable stress model in ratsGrazyna Ossowska, Gabriel Nowak, Bozena Klenk-Majewska, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|October 11, 2012
Serotonin transporter activity of imidazolidine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives in aspect of their acid-base propertiesAgnieszka Zagórska, Anna Czopek, Maciej Pawłowski, et al.
Pharmacology & Therapeutics|August 28, 2018
Zinc signaling and epilepsyUrszula Doboszewska, Katarzyna Młyniec, Aleksandra Wlaź, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Repeated Sulforaphane Treatment Reverses Depressive-like Behavior and Exerts Antioxidant Effects in the Olfactory Bulbectomy Model in MicePatrycja Pańczyszyn-Trzewik, Katarzyna Stachowicz, Paulina Misztak, et al.
Inflammopharmacology|January 25, 2012
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitorsMichael Maes, Zdenĕk Fišar, Miguel Medina, et al.
Pharmacology, Biochemistry, and Behavior|May 26, 2004
Antidepressant- and anxiolytic-like activity of magnesium in miceEwa Poleszak, Bernadeta Szewczyk, Ewa Kedzierska, et al.
Pageof 19

Showing results (51-60 of 187) with videos related to

Sort By:
Pageof 19
Pharmacological Reports : PR|August 17, 2013
Zinc deficiency alters responsiveness to antidepressant drugs in miceKatarzyna Młyniec, Bogusława Budziszewska, Witold Reczyński, et al.
European Journal of Pharmacology|May 18, 2004
Zinc treatment induces cortical brain-derived neurotrophic factor gene expressionGabriel Nowak, Beata Legutko, Bernadeta Szewczyk, et al.
Molecules (Basel, Switzerland)|January 11, 2022
Antidepressant-like Effects of Combined Fluoxetine and Zinc Treatment in Mice Exposed to Chronic Restraint Stress Are Related to Modulation of Histone DeacetylasePaulina Misztak, Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, et al.
Neurotoxicity Research|June 4, 2017
Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in RodentsPiotr Popik, Małgorzata Hołuj, Tomasz Kos, et al.
Polish Journal of Pharmacology|July 26, 2002
Effect of imipramine on brain D-1 and 5-HT-2A receptors in a chronic unpredictable stress model in ratsGrazyna Ossowska, Gabriel Nowak, Bozena Klenk-Majewska, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|October 11, 2012
Serotonin transporter activity of imidazolidine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives in aspect of their acid-base propertiesAgnieszka Zagórska, Anna Czopek, Maciej Pawłowski, et al.
Pharmacology & Therapeutics|August 28, 2018
Zinc signaling and epilepsyUrszula Doboszewska, Katarzyna Młyniec, Aleksandra Wlaź, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Repeated Sulforaphane Treatment Reverses Depressive-like Behavior and Exerts Antioxidant Effects in the Olfactory Bulbectomy Model in MicePatrycja Pańczyszyn-Trzewik, Katarzyna Stachowicz, Paulina Misztak, et al.
Inflammopharmacology|January 25, 2012
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitorsMichael Maes, Zdenĕk Fišar, Miguel Medina, et al.
Pharmacology, Biochemistry, and Behavior|May 26, 2004
Antidepressant- and anxiolytic-like activity of magnesium in miceEwa Poleszak, Bernadeta Szewczyk, Ewa Kedzierska, et al.
Pageof 19